Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Medicine,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s10143-023-02104-2.pdf
Reference51 articles.
1. Anetsberger A, Gempt J, Blobner M et al (2020) Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage: randomized controlled trial. Stroke 51:2287–2296. https://doi.org/10.1161/STROKEAHA.120.029279
2. Barth M, Capelle HH, Münch E et al (2007) Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Acta Neurochir (Wien) 149:911–918. https://doi.org/10.1007/s00701-007-1249-3
3. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K et al (2003) Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238:641–648. https://doi.org/10.1097/01.sla.0000094387.50865.23
4. Bruder N, Rabinstein A, Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage (2011) Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care 15:257–269. https://doi.org/10.1007/s12028-011-9598-4
5. Connolly ES, Rabinstein AA, Carhuapoma JR et al (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American stroke association. Stroke 43:1711–1737. https://doi.org/10.1161/STR.0b013e3182587839
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiopulmonary Events of the Elderly (≥75 Years) during Clazosentan Therapy after Subarachnoid Hemorrhage: A Retrospective Study from a Tertiary Stroke Center in Japan;Medicina;2024-01-21
2. Initial results of clazosentan with multiple-drug management for the prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage;Brain Hemorrhages;2024-01
3. Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm;Brain Hemorrhages;2023-12
4. Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes;Brain Hemorrhages;2023-11
5. Clazosentan/fasudil;Reactions Weekly;2023-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3